🇺🇸 FDA
Patent

US 8426425

Aminopyrimidines useful as inhibitors of protein kinases

granted A61PA61P11/06A61P19/02

Quick answer

US patent 8426425 (Aminopyrimidines useful as inhibitors of protein kinases) held by Vertex Pharmaceuticals Incorporated expires Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Vertex Pharmaceuticals Incorporated
Grant date
Tue Apr 23 2013 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2033 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
33
CPC classes
A61P, A61P11/06, A61P19/02, A61P19/08, A61P19/10